Related Experiment Videos
[Experimental study on N-isopropyl-p-iodoamphetamine lung uptake]
S Kosuda1, S Kawahara, A Ishibashi
1Department of Radiology, Tokyo Metropolitan Komagome Hospital.
Kaku Igaku. the Japanese Journal of Nuclear Medicine
|February 1, 1990
Summary
This study investigated N-isopropyl-p-iodoamphetamine (IMP) lung uptake in rats. IMP passes through the capillary-alveolar barrier, reaching alveolar spaces after intravenous injection, even in irradiated lungs.
Area of Science:
- Pharmacology
- Radiology
- Pulmonary Medicine
Context:
- Investigating the pharmacokinetic behavior of radiolabeled compounds in lung tissue.
- Utilizing microautoradiography to visualize drug distribution at a cellular level.
- Assessing the impact of radiation therapy on drug uptake in the lungs.
Purpose:
- To determine the lung uptake and distribution of N-isopropyl-p-iodoamphetamine (IMP) in rats.
- To evaluate whether radiation exposure affects IMP's ability to cross the capillary-alveolar barrier.
- To understand the cellular localization of IMP in lung tissue over time.
Summary:
- Wistar rats were intravenously injected with 125I-IMP, and lung tissue was analyzed using microautoradiography.
- One minute post-injection, increased grain density (indicating IMP) was observed in the interstitial space, including capillaries and interalveolar septa, but not alveoli.
- Twenty-four hours post-injection, increased grain density was noted in the alveolar space of irradiated lungs, though no significant difference was found between irradiated and non-irradiated lungs, suggesting IMP can traverse the capillary-alveolar barrier.
Impact:
- Provides insights into the pulmonary pharmacokinetics of IMP.
- Suggests that IMP can penetrate the lung's capillary-alveolar barrier.
- Informs potential therapeutic or diagnostic applications of IMP in lung conditions, including those affected by radiation.